QQ客服 官方微博 反馈留言

	Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial
	Yang Wenying; Liu Jie; Shan Zhongyan; Tian Haoming; Zhou Zhiguang; Ji Qiuhe; Weng Jianping; Jia Weiping; Lu Juming; Liu Jing
	2014
卷号	2期号:1页码:46-55
ISSN号	2213-8595
DOI	10.1016/S2213-8587(13)70021-4
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6671089
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yang Wenying,Liu Jie,Shan Zhongyan,et al. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial[J],2014,2(1):46-55.
APA	Yang Wenying.,Liu Jie.,Shan Zhongyan.,Tian Haoming.,Zhou Zhiguang.,...&Chen Wei.(2014).Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.,2(1),46-55.
MLA	Yang Wenying,et al."Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial".2.1(2014):46-55.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。